Revenue and adjusted EBITDA exceeded guidance, with strong cash flow and a major customer expansion to over $10M ARR. Strategic cohorts and generative AI drove growth, while guidance for FY27 remains unchanged amid healthy demand and disciplined investment.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.